A Buzyn
Overview
Explore the profile of A Buzyn including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
47
Citations
715
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Carreras E, Cahn J, Puozzo C, Kroger N, Sanz G, Buzyn A, et al.
Anticancer Res
. 2010 Aug;
30(7):2977-84.
PMID: 20683042
This study investigated the effect of seizure prophylaxis on busulfan (Bu) plasma exposure. Twenty-four adult patients received an intravenous Bu-cyclophoshamide conditioning regimen prior to bone marrow transplantation. Busilvex (0.8 mg/kg)...
12.
Willems L, Suarez F, Messas E, Baubion N, Decaudin D, Fourquet A, et al.
Bull Cancer
. 2009 Oct;
97(2):245-54.
PMID: 19819776
Secondary acute myeloid leukaemia (AML) occurring after breast cancer is a rare long-term complication of the chemo- and/or radiation therapy required to treat breast cancer. The usually recognized curative option...
13.
Daguindau E, Lioure B, Buzyn A, Robin M, Faucher C, Kuentz M, et al.
Bone Marrow Transplant
. 2009 May;
45(1):177-80.
PMID: 19430502
Remissions of haematological malignancies have been reported after allo-SCT, despite donor cell rejection, suggesting that sustained allogeneic engraftment is not mandatory to obtain a lasting anti-tumour effect. To evaluate the...
14.
Duchet-Niedziolka P, Launay O, Coutsinos Z, Ajana F, Arlet P, Barrou B, et al.
Vaccine
. 2009 Jan;
27(10):1523-9.
PMID: 19168104
Introduction: There are insufficient data regarding the efficacy and safety of vaccination in patients with auto-immune disease (AID) and/or drug-related immune deficiency (DRID). The objective of this study was to...
15.
Suarez F, Lortholary O, Buland S, Rubio M, Ghez D, Mahe V, et al.
J Clin Microbiol
. 2008 Oct;
46(11):3772-7.
PMID: 18845828
Detection of galactomannan antigen (GMA) in serum is the standard assay for the diagnosis of invasive aspergillosis (IA) in high-risk patients with hematological disorders. Detection of Aspergillus DNA in serum...
16.
Tavernier E, Boiron J, Huguet F, Bradstock K, Vey N, Kovacsovics T, et al.
Leukemia
. 2007 Jul;
21(9):1907-14.
PMID: 17611565
Fifty-four percent of adults with acute lymphoblastic leukemia (ALL) who entered the LALA-94 trial experienced a first relapse. We examined the outcome of these 421 adult patients. One hundred and...
17.
Carrie E, Buzyn A, Fraitag S, Hermine O, Bodemer C
Ann Dermatol Venereol
. 2007 May;
134(5 Pt 1):471-6.
PMID: 17507848
Background: Mycosis fungoides is the most frequent cutaneous T-cell lymphoma but has been rarely reported in children and teenagers. Although transformation into large-cell T-cell lymphoma has been described in 10%...
18.
Vey N, Thomas X, Picard C, Kovascovicz T, Charin C, Cayuela J, et al.
Leukemia
. 2006 Oct;
20(12):2155-61.
PMID: 17039234
Adult patients with acute lymphoblastic leukemia (ALL) and t(1;19)/E2A-PBX1 or t(4;11)/MLL-AF4 have a poor outcome. We have evaluated the impact of an intensified post-remission therapy using a high-dose chemotherapy course...
19.
Delannoy A, Delabesse E, Lheritier V, Castaigne S, Rigal-Huguet F, Raffoux E, et al.
Leukemia
. 2006 Jul;
20(9):1526-32.
PMID: 16838024
Acute lymphoblastic leukemia (ALL) in the elderly is characterized by its ominous prognosis. On the other hand, imatinib has demonstrated remarkable, although transient, activity in relapsed and refractory Philadelphia-positive acute...
20.
Asnafi V, Rubio M, Delabesse E, Villar E, Davi F, Damaj G, et al.
Leukemia
. 2006 Mar;
20(5):793-9.
PMID: 16541140
Chronic myeloid leukemia (CML) relapse after allogeneic stem cell transplantation (SCT) is a relatively frequent situation, which is correlated to disease status, time from diagnosis to transplant and T-cell depletion....